| |
|
|
|
Oxford Global, San Diego, CA
2024-10-28
Built with industry experts in mind, the conference program highlights: - Exciting biomarker technologies impacting R&D in 2024
- Multi-omics, spatial biology, digital markers, and next-gen diagnostics
- The opportunity to engage with regulators, diagnostics manufacturers, and biopharma peers
Take a look here and discover the Biomarkers US 2024 agenda!
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
Meet our Key Speakers - Kristina McGuire, Executive Director & Head, CDx & Laboratory Operations, Regeneron
- Robert Getzenberg, Medical Director Diagnostics, Oncology, Astellas
- Satya Saxenda, Director, Global Proteomics, Clinical Pharmacology & Translational Medicine, Eisai
- Lokesh Agrawal, Program Director, National Cancer Institute
- Heather Cohen, Senior Director, Translational Sciences, Bicycle Therapeutics
- Nandini Rudraganguly, Associate Director, Precision Medicine Oncology, AbbVie
- Anand Giddabasappa, Head of Global Science & Technology, Pfizer
- Jean-Francois Martin, Executive Director – Diagnostics & Translational Oncology, Pfizer
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
Register here! Includes complimentary access to open conference sessions, refreshments, and drinks reception.
|
|
|
E-mail:
|
|
l.staplehurst@oxfordglobal.com
|
|
|
|
|
|
|
|
|
|
|
|
|